These results indicate that endocannabinoid catabolicenzymes are promising targets to treat opioid dependence.
2
Most of them result from mutations in genes encoding for the catabolicenzymes that ensure intralysosomal digestion.
3
Efforts have also been made to summarize the biodegradation mechanisms and catabolicenzymes involved in glyphosate metabolism.
4
Most structural genes encoding nitrogen catabolicenzymes are subject to nitrogen catabolite repression, mediated by positive-acting transcription factors of the GATA family of proteins.